ArticleCancer research communications2026

SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

Pauline du Rusquec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.